IRADIMED CORPORATION: 10-Q filed 2025-05-05

Name: IRADIMED CORPORATION: 10-Q filed 2025-05-05
Creator: IRADIMED CORPORATION

What IRADIMED CORPORATION reported in its quarterly report filed 2025-05-05 (fiscal Q1 2025): 51 published measures, 105 facts as tagged in accession 0001558370-25-006308.

This filing

Form: 10-Q (quarterly report)
Filed: 2025-05-05
Fiscal period: fiscal Q1 2025
Accession: 0001558370-25-006308 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All IRADIMED CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2025-03-31	101,729,435	USD
At 2024-12-31	98,325,775	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2025-03-31	11,675,005	USD
At 2024-12-31	11,507,019	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2025-03-31	90,054,430	USD
At 2024-12-31	86,818,756	USD
At 2024-03-31	76,121,462	USD
At 2023-12-31	71,420,164	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2025-03-31	50,330,880	USD
At 2024-12-31	52,233,907	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	4,687,429	USD	90
2024-01-01 to 2024-03-31	4,136,533	USD	91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	4,292,092	USD	90
2024-01-01 to 2024-03-31	3,883,154	USD	91

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	3,697,468	USD	90
2024-01-01 to 2024-03-31	270,566	USD	91

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	19,510,637	USD	90
2024-01-01 to 2024-03-31	17,598,119	USD	91

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	19,510,637	USD	90
2024-01-01 to 2024-03-31	17,598,119	USD	91

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	-2,277,819	USD	90
2024-01-01 to 2024-03-31	-8,039,873	USD	91

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	-3,917,300	USD	90
2024-01-01 to 2024-03-31	-478,803	USD	91

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2025-03-31	59,316,658	USD
At 2024-12-31	56,790,751	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	12,714,224	shares	90
2024-01-01 to 2024-03-31	12,662,526	shares	91

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	12,825,672	shares	90
2024-01-01 to 2024-03-31	12,749,973	shares	91

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	0.37	USD/shares	90
2024-01-01 to 2024-03-31	0.33	USD/shares	91

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	0.37	USD/shares	90
2024-01-01 to 2024-03-31	0.32	USD/shares	91

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	1,258,000	USD	90
2024-01-01 to 2024-03-31	1,106,968	USD	91

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2025-03-31	20,377,795	USD
At 2024-12-31	16,810,797	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	826,064	USD	90
2024-01-01 to 2024-03-31	628,640	USD	91

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	5,431,456	USD	90
2024-01-01 to 2024-03-31	4,748,347	USD	91

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2025-03-31	75,136,765	USD
At 2024-12-31	75,242,219	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2025-03-31	8,473,444	USD
At 2024-12-31	8,512,308	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2025-03-31	2,590,044	USD
At 2024-12-31	1,896,405	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2025-03-31	3,258,759	USD
At 2024-12-31	3,098,691	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2025-03-31	12,706,192	USD
At 2024-12-31	10,556,733	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	9,411,350	USD	90
2024-01-01 to 2024-03-31	8,639,376	USD	91

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2025-03-31	10,555,729	USD
At 2024-12-31	10,401,889	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	14,842,806	USD	90
2024-01-01 to 2024-03-31	13,387,723	USD	91

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	4,667,831	USD	90
2024-01-01 to 2024-03-31	4,210,396	USD	91

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	624,245	USD	90
2024-01-01 to 2024-03-31	821,000	USD	91

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2025-03-31	12,715,109	shares
At 2024-12-31	12,709,860	shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2025-03-31	50,330,880	USD
At 2024-12-31	52,233,907	USD
At 2024-03-31	45,126,676	USD
At 2023-12-31	49,762,198	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2025-03-31	30,736,500	USD
At 2024-12-31	30,026,734	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2025-03-31	59,221	USD
At 2024-12-31	154,688	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2025-03-31	59,221	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2025-03-31	25,107,657	USD
At 2024-12-31	21,406,304	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2025-03-31	4,729,862	USD
At 2024-12-31	4,595,507	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2025-03-31	206,009	USD
At 2024-12-31	198,912	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2025-03-31	1,543,964	USD
At 2024-12-31	2,049,690	USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

Period	Value	Unit	Days
At 2025-03-31	2,598,549	USD
At 2024-12-31	2,259,616	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	5,945,429	USD	90
2024-01-01 to 2024-03-31	5,243,501	USD	91

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	4,687,429	USD	90
2024-01-01 to 2024-03-31	4,136,533	USD	91

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	4,610,832	USD	90
2024-01-01 to 2024-03-31	3,991,211	USD	91

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	134,355	USD	90
2024-01-01 to 2024-03-31	168,657	USD	91

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	194,122	USD	90
2024-01-01 to 2024-03-31	226,089	USD	91

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	59,764	USD	90
2024-01-01 to 2024-03-31	57,432	USD	91

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	513,973	USD	90
2024-01-01 to 2024-03-31	495,154	USD	91

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	9,000	USD	90
2024-01-01 to 2024-03-31	189,595	USD	91

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	2,134,549	USD	90
2024-01-01 to 2024-03-31	764,322	USD	91

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	120,010	USD	90
2024-01-01 to 2024-03-31	-93,052	USD	91

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2025-01-01 to 2025-03-31	693,639	USD	90
2024-01-01 to 2024-03-31	-640,320	USD	91

Inspect the source

Entity: IRADIMED CORPORATION / CIK 0001325618
Captured: 2026-09-20T07:52:33.517Z
SEC response SHA-256: 1217db54631fdc625eb836a9c89fbf1ed157044af9ce59b6e200421c6d8ca994

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001325618.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))